rs397517433
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4
The NM_032119.4(ADGRV1):c.6676G>A(p.Glu2226Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000202 in 1,581,674 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_032119.4 missense
Scores
Clinical Significance
Conservation
Publications
- Usher syndrome type 2Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Usher syndrome type 2CInheritance: AR Classification: STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- febrile seizures, familial, 4Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- nonsyndromic genetic hearing lossInheritance: AR Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152146Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.00000501 AC: 1AN: 199796 AF XY: 0.00000935 show subpopulations
GnomAD4 exome AF: 0.0000203 AC: 29AN: 1429528Hom.: 0 Cov.: 29 AF XY: 0.0000198 AC XY: 14AN XY: 708444 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152146Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74322 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The Glu2226Lys vari ant in GPR98 has not been previously identified by our laboratory and it has not been identified in large and broad African American and European American popul ations by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/) . Computational analyses (biochemical amino acid properties, conservation, Align GVGD, PolyPhen2, and SIFT) suggest that the Glu2226Lys variant may not impact th e protein, particularly with the Glu2226 amino acid not conserved in rat or lowe r species. However, this information is not predictive enough to rule out pathog enicity. In summary, the clinical significance of this variant cannot be determi ned with certainty; however based upon the reduced conservation, we would lean t owards a more likely benign role. -
Inborn genetic diseases Uncertain:1
The c.6676G>A (p.E2226K) alteration is located in exon 30 (coding exon 30) of the ADGRV1 gene. This alteration results from a G to A substitution at nucleotide position 6676, causing the glutamic acid (E) at amino acid position 2226 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at